NCT05273502

Brief Summary

Social innovation in aging needs to bring new ideas and services to meet new social and welfare needs identified in recent years. In our environment, people ≥60 years old accounted for 20% -24% of the population in 2015, and it is expected to increase to ≥30% by 2050. Older people living in rural areas have been severely affected by confinement, and new needs are being generated. To better understand the needs, an innovative element of this project is to involve the elderly-young people (60-74 years) from rural areas in the generation of solutions, which will make these solutions especially adapted to their needs. It also aims to study the effectiveness of a health education intervention based on participatory research, where young seniors co-create and implement the intervention among their peers, and focused on improving lifestyles, to prevent or to improve sarcopenia. The objectives of this project are: To characterize the elderly (60 to 74 years) who live independently in rural areas of the province of Tarragona, to actively involve them, through a process of participatory research to generate solutions. To achieve this goal, it is proposed to make a diagnosis of their health status (lifestyles, risk of malnutrition and sarcopenia), and conduct group interviews (focus groups) including earlier elderly people from rural areas. In addition, participants will receive the intervention co-created by themselves, and the effectiveness of the intervention created will be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
176

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2022

Completed
12 days until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 10, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

February 17, 2022

Last Update Submit

March 15, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Risk of sarcopenia (muscle strength)

    Change of muscle strength: \<27kg in men and \<16kg in women measured by a dynamometer

    Baseline and through study completion, an average of 1 year

  • Diagnosis of sarcopenia (muscle strength)

    Change of muscle strength (\<27kg in men and \<16kg in women measured by a dynamometer)

    Baseline and through study completion, an average of 1 year

  • Diagnosis of sarcopenia (muscle mass)

    Change of muscle mass (\<20kg in men and \<15kg in women measured by bioimpedance)

    Baseline and through study completion, an average of 1 year

  • Diagnosis of severe sarcopenia (muscle strength)

    Change of muscle strength (\<27kg in men and \<16kg in women measured by a dynamometer)

    Baseline and through study completion, an average of 1 year

  • Diagnosis of severe sarcopenia (muscle mass)

    Change of muscle mass (\<20kg in men and \<15kg in women measured by bioimpedance)

    Baseline and through study completion, an average of 1 year

  • Diagnosis of severe sarcopenia (muscle function)

    Change of muscle function (≤0.8 m / s)

    Baseline and through study completion, an average of 1 year

Secondary Outcomes (6)

  • Nutrition

    Baseline and through study completion, an average of 1 year

  • Physical activity

    Baseline and through study completion, an average of 1 year

  • Sleep behaviour

    Baseline and through study completion, an average of 1 year

  • Risk of malnutrition

    Baseline and through study completion, an average of 1 year

  • Weight

    Baseline and through study completion, an average of 1 year

  • +1 more secondary outcomes

Other Outcomes (2)

  • Age

    Baseline and through study completion, an average of 1 year

  • Gender

    Baseline

Study Arms (2)

Citizen Science Behavioral Intervention

EXPERIMENTAL

The intervention group (IG) participants will receive the whole citizen science intervention of the project, and participants will be assessed at baseline and end-of-study.

Behavioral: Citizen Science intervention

Control group

NO INTERVENTION

The controls group (CG) participants will not receive any kind of intervention, and participants will only be assessed at baseline and end-of-study.

Interventions

Intervention generated by a participatory research process (co-creation) in the elderly population living in rural areas to co-create solutions to improve their lifestyles, quality of life and health.

Citizen Science Behavioral Intervention

Eligibility Criteria

Age60 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • People ≥60 years and ≤74 years,
  • That they have informed consent,
  • Living at home (living independently), Community-dwelling early-elderly
  • That they can continue the study,
  • They live in the province of Tarragona.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Rovira i Virgili

Reus, Tarragona, Spain

RECRUITING

MeSH Terms

Conditions

Health BehaviorSarcopeniaMotor Activity

Condition Hierarchy (Ancestors)

BehaviorMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Central Study Contacts

Rosa Solà, Dr

CONTACT

Lucia Tarro, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This is an educational program, so that, the intervention group will know that will receive some educational and behavioral activities, and the control group will know that they will not receive any kind of activities.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial (cluster)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD. Full professor

Study Record Dates

First Submitted

February 17, 2022

First Posted

March 10, 2022

Study Start

March 1, 2022

Primary Completion

May 15, 2022

Study Completion

December 30, 2023

Last Updated

March 31, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations